The biotech scorecard for Q2: 18 stock-moving events to watch

The biotech scorecard for Q2: 18 stock-moving events to watch

STAT Plus: The biotech scorecard for the second quarter: 18 stock-moving events to watch

By ADAM FEUERSTEIN

RYAN PIERSE/GETTY IMAGES

Here are the key biotech events we’re watching for in the second quarter of 2019, including readouts from Intercept Pharmaceuticals, Biomarin, and Pfizer.

READ MORE